Matricellular proteins in cardiac adaptation and disease

NG Frangogiannis - Physiological reviews, 2012 - journals.physiology.org
The term matricellular proteins describes a family of structurally unrelated extracellular
macromolecules that, unlike structural matrix proteins, do not play a primary role in tissue …

The PDGF system and its antagonists in liver fibrosis

E Borkham-Kamphorst, R Weiskirchen - Cytokine & growth factor reviews, 2016 - Elsevier
Platelet derived growth factor (PDGF) signaling plays an important role in activated hepatic
stellate cells and portal fibroblast proliferation, chemotaxis, migration and cell survival …

The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

FJ Barreyro, S Holod, PV Finocchietto… - Liver …, 2015 - Wiley Online Library
Abstract Background & Aims Hepatocyte apoptosis, the hallmark of non‐alcoholic
steatohepatitis (NASH) contributes to liver injury and fibrosis. Although, both the intrinsic and …

The role of SPARC in extracellular matrix assembly

AD Bradshaw - Journal of cell communication and signaling, 2009 - Springer
SPARC is a collagen-binding matricellular protein. Expression of SPARC in adult tissues is
frequently associated with excessive deposition of collagen and SPARC-null mice fail to …

TGF-β1 is a negative regulator of lymphatic regeneration during wound repair

NW Clavin, T Avraham, J Fernandez… - American Journal …, 2008 - journals.physiology.org
Although clinical studies have identified scarring/fibrosis as significant risk factors for
lymphedema, the mechanisms by which lymphatic repair is impaired remain unknown …

SPARC: a key player in the pathologies associated with obesity and diabetes

K Kos, JPH Wilding - Nature reviews endocrinology, 2010 - nature.com
SPARC (secreted protein acidic and rich in cysteine, also known as osteonectin or BM-40) is
a widely expressed profibrotic protein with pleiotropic roles, which have been studied in a …

ERK pathway in activated, myofibroblast-like, hepatic stellate cells: a critical signaling crossroad sustaining liver fibrosis

B Foglia, S Cannito, C Bocca, M Parola… - International journal of …, 2019 - mdpi.com
Fibrogenic progression of chronic liver disease, whatever the etiology, is characterized by
persistent chronic parenchymal injury, chronic activation of inflammatory response, and …

Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction

D Fan, A Takawale, R Basu, V Patel, J Lee… - Cardiovascular …, 2014 - academic.oup.com
Aims Tissue inhibitor of metalloproteinases (TIMPs) can mediate myocardial remodelling,
hypertrophy, and fibrosis in heart disease. We investigated the impact of TIMP2 vs. TIMP3 …

Hepatoprotective and anti-fibrotic agents: It's time to take the next step

R Weiskirchen - Frontiers in pharmacology, 2016 - frontiersin.org
Hepatic fibrosis and cirrhosis cause strong human suffering and necessitate a monetary
burden worldwide. Therefore, there is an urgent need for the development of therapies. Pre …

Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose

K Kos, S Wong, B Tan, A Gummesson, M Jernas… - Diabetes, 2009 - Am Diabetes Assoc
OBJECTIVE Matricellular Secreted Protein, Acidic and Rich in Cysteine (SPARC), originally
discovered in bone as osteonectin, is a mediator of collagen deposition and promotes …